Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trialHiddo J.L. Heerspink, Chris Vercammen, Ricardo Correa-Rotter et al.|The Lancet|2019Cited by 609
Global variation in renal replacement therapy for end-stage renal diseaseFergus Caskey, Kitty J. Jager, Anneke Kramer et al.|Nephrology Dialysis Transplantation|2011Cited by 120